Medical Equipment

Sacral Nerve Stimulation Devices Market Size Outlook and Demand Growth Across 2026–2030

March 17, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Is The Market Size Of The Sacral Nerve Stimulation Devices Market Expected To Change Between 2026 And 2030?

The sacral nerve stimulation devices market size has undergone rapid expansion in recent years. It is expected to grow from $1.48 billion in 2025 to $1.65 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 11.5%. The expansion witnessed in the historic period can be linked to the growing prevalence of urinary incontinence, an increasing geriatric population, advancements in neuromodulation technology, a wider clinical acceptance of nerve stimulation therapies, and the expansion of urology specialty services.

The sacral nerve stimulation devices market size is forecast to grow rapidly over the next few years. It is expected to expand to $2.54 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 11.4%. The projected growth can be attributed to several factors including the rising adoption of smart implantable devices, increasing demand for long-term continence management solutions, the expansion of outpatient neuromodulation procedures, a growing focus on personalized neurological therapies, and increasing investments in bioelectronic medicine. Key trends during this forecast period include the increasing uptake of implantable neuromodulation devices, a rising need for minimally invasive bladder control treatments, the growing integration of programmable stimulation technologies, the expansion of long-term neurological therapy solutions, and an enhanced focus on patient-specific therapy customization.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18458&type=smp

What Underlying Factors Are Accelerating The Growth Of The Sacral Nerve Stimulation Devices Market?

The expanding occurrence of urological ailments is anticipated to drive the future growth of the sacral nerve stimulation devices market. These conditions involve a variety of issues impacting the urinary tract, kidneys, bladder, and prostate, with durations ranging from short-term to persistent. Urological disorders originate from diverse factors, influencing both the urinary and reproductive systems. Furthermore, lifestyle choices like inadequate diet, insufficient hydration, and lack of physical activity can contribute to the formation of kidney stones, a painful condition affecting the urinary tract. Sacral nerve stimulation devices offer a less invasive treatment approach capable of effectively managing urological issues such as urinary and fecal incontinence. As an illustration, in April 2024, data from the National Institute of Diabetes and Digestive and Kidney Diseases, a US-based healthcare company, revealed that, on average annually, 651,446 individuals aged 65 and older (212,875 men and 438,572 women) received a new diagnosis of some type of urinary incontinence. Consequently, the rising incidence of urological disorders is set to fuel the expansion of the sacral nerve stimulation devices market.

How Is The Sacral Nerve Stimulation Devices Market Structured Across Different Segments?

The sacral nerve stimulation devices market covered in this report is segmented –

1) By Technology Modality: Implantable Sacral Neuromodulation, External Sacral Neuromodulation

2) By Product: External Sacral Nerve Stimulation Devices, Implantable Sacral Nerve Stimulation Devices

3) By Age Group: Pediatrics, Adults, Geriatrics

4) By Application: Urinary Incontinence, Fecal Incontinence, Bowel Dysfunction, Other Applications

5) By End User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics

Subsegments:

1) By Implantable Sacral Neuromodulation: Rechargeable Implantable SNS Systems, Non-Rechargeable Implantable SNS Systems

2) By External Sacral Neuromodulation: Transcutaneous Sacral Neuromodulation Systems, Wearable External Neuromodulation Devices

Which Trends Are Shaping The Future Of The Sacral Nerve Stimulation Devices Market?

Leading companies within the Sacral Nerve Stimulation (SNS) devices market are prioritizing the creation of advanced solutions, such as recharge-free sacral neuromodulation systems, aimed at improving patient ease of use and compliance with treatment. These recharge-free systems are implantable devices designed to stimulate sacral nerves, addressing bladder and bowel dysfunction without the need for periodic battery recharges. For instance, Medtronic PLC, an Ireland-based medical technology firm, secured FDA approval in January 2025 for its InterStim X Sacral Neuromodulation (SNM) system in India. This system is intended for managing bladder and bowel control problems, specifically overactive bladder (OAB), chronic fecal incontinence (FI), and non-obstructive urinary retention. The systems incorporate a unique fifth-generation battery capable of delivering more than 10 years of therapy without requiring a recharge, with this duration potentially reaching 15 years when operating on low-energy settings. Additionally, it includes a smart programmer, similar to a smartphone, empowering patients to privately modify up to 11 therapy settings from their home or while mobile. Furthermore, the system is compatible with SureScan MRI technology, enabling patients to safely undergo full-body 1.5T and 3T MRI scans, and the MRI mode can be simply managed by the patient following a physician’s instructions.

Which Major Players Dominate The Sacral Nerve Stimulation Devices Market?

Major companies operating in the sacral nerve stimulation devices market are Abbott, Medtronic plc, Boston Scientific Corporation, Axonics Modulation Technologies, Laborie Medical Technologies, Beijing PINS Medical Co. Ltd., Neuspera Medical, Coloplast Group, Medtronic Neurovascular, NeuroPace Inc., Aleva Neurotherapeutics, LivaNova Neuromodulation, Nalu Medical, SetPoint Medical, NeuroSigma Inc., Saluda Medical, Soterix Medical, Inspire Medical Systems Inc., Synapse Biomedical Inc., Bioinduction Ltd

Read the full sacral nerve stimulation devices market report here:

https://www.thebusinessresearchcompany.com/report/sacral-nerve-stimulation-devices-global-market-report

Which Region Is Projected To Dominate The Sacral Nerve Stimulation Devices Market During The Forecast Period?

North America was the largest region in the sacral nerve stimulation devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sacral nerve stimulation devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Sacral Nerve Stimulation Devices Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=18458&type=smp

Browse Through More Reports Similar to the Global Sacral Nerve Stimulation Devices Market 2026, By The Business Research Company

Electrical Stimulation Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/electrical-stimulation-devices-global-market-report

Spinal Cord Stimulation Market Report 2026

https://www.thebusinessresearchcompany.com/report/spinal-cord-stimulation-global-market-report

Neurostimulation Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/neurostimulation-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795